Molecular and Translational Oncology – Life Sciences & Technologies

Cycle XXXVII (2021/2022)

DETAILS OF A.Y. 2021/2022 PH.D. PROGRAMME IN “Molecular and Translational Oncology and Innovative Medical Surgical Technologies”

EDUCATIONAL OBJECTIVES	The aim of the Ph.D. is to train professionals with interdisciplinary skills in oncological research, autonomy in planning, execution and interpretation of experiments, formulation of research projects and writing of scientific articles.
Curriculum 1	Molecular Oncology. Main objectives: Study of the molecular alterations involved in the onset, progression and dispersal of family and sporadic tumours, through experimental models in vitro, ex-vivo and in vivo. Use of “highthroughput” approaches for the definition of tumour genomic and epigenomic panorama, proteomics and metabolics.
Curriculum 2	Biomedical Engineering, Systems and Nanotechnologies applied to Oncology. Main objectives: Methods and technologies for the modelling, simulation, and control of biological systems, the elaboration of images aimed at the planning of therapeutic interventions, the planning of nanotechnologies based innovative biomedical devices.
Curriculum 3	Medical and Translational Oncology. Main objectives: Innovative approaches for the development of high-selectivity diagnostic, therapeutic and/or pre-emptive strategies in medical oncology.
Curriculum 4	Innovative technologies and therapies in urological, gynaecological surgery and in fertility preservation.Main objectives: clinical research methodology applies to oncological pathologies relating to urology and gynaecology (primary prevention, precocious diagnosing and treatment) and to innovative fertility preservation therapies.
Programme Duration	3 years
Coordinator	Prof. Giovanni Cuda